Revision History
Claude for Life Sciences · 9 revisions
Sizes are character counts of the article source. The signed number is the change from the previous revision.
Recent edit summaries
Detailed summaries recorded by editors. Generic maintenance summaries are omitted here; every recorded revision remains below. Dates describe the edit, not necessarily the event it covers.
- Correction: Xaira, Edison and Manifold Bio were quoted, not described as early participants; beta, not public beta
Version 9 · Sep 29, 2026, 07:12 AM
- Correction: no proposal form on the post; the reverse transcriptase itself was already known; TNW author added (verifier V1)
Version 8 · Sep 27, 2026, 06:54 PM
- Correction: Opus 5.5 was deployed with safeguards 'similar to' (not 'the same as') Fable 5.1's and the 'impeded' wording was unsupported; Benchling press release was Oct 20, 2025 (not the Coefficient Bio deal day); wet-lab quote now verbatim from Reuters; Proteinbase quotes now match '$1 million+'. Update: Sep 2026 research group and lab (BSL-1/2, human-run), ART reverse-transcriptase discovery, call for proposals, competition tracks, Reuters robotics reporting, Novo Nordisk collaboration.
Version 7 · Sep 27, 2026, 06:44 PM
- Link [Twist Bioscience] to the new twist_bioscience article
Version 6 · Sep 23, 2026, 12:10 PM
- Verification fixes: Protocol QA methodology attribution; unsourced first-vertical and reception claims removed; schedule citation; non-cash prizes; LSVP wording; duplicate MCP link
Version 5 · Sep 23, 2026, 07:50 AM